Spontaneous Remission and Subsequent Relapse in Pediatric Acute Myeloid Leukemia (AML-M5): A Case Report and Literature Review.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
Spontaneous remission (SR) in pediatric acute myeloid leukemia (AML-M5) is extremely rare and is typically characterized by short duration and high relapse risk. We report a case of AML-M5 in a child at Yunnan Children's Medical Center who achieved SR following blood transfusions and anti-infective therapy, without leukemia-specific treatment, but relapsed one month later. A comprehensive literature review was also conducted to explore factors contributing to SR in pediatric leukemia, with the aim of informing treatment protocols and improving outcomes for AML patients.